New research has found that pimavanserin significantly improves psychosis symptoms in people with Alzheimer’s disease, without the devastating side-effects of currently used antipsychotics. The research found an even greater benefit in those with the most severe psychotic symptoms.

https://www.sciencedaily.com/releases/2018/02/180213183620.htm